BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

J. Randall Good Joins SRI International as Program Development Director, DARPA and Intelligence


8/31/2012 8:48:44 AM

MENLO PARK, Calif., Aug. 30, 2012 /PRNewswire/ -- J. Randall Good, Ph.D., has joined SRI International as program development director, DARPA and Intelligence.

In this new role, he will expand SRI's relationship with key clients and develop programs that serve critical security and technical needs.

"Dr. Good has outstanding credentials, having been in key management and staff positions in companies working in the government sector," said Jerry Harrison, vice president and general manager of Government Business Development at SRI International. "His broad technical background and excellent customer knowledge will be an asset to SRI as we serve the evolving security and defense needs of our clients."

Prior to joining SRI, Good served as director, Science & Technology Programs at ENSCO, Inc., where he was responsible for the integration of technical solutions into client programs, developing future technology visions for the company, and capturing new business opportunities.

Earlier, he was division director, Intelligence and Advanced Technology, at Noblis, where he focused on the development and implementation of concept-to-prototype R&D capabilities for the intelligence community. His experience also includes the Institute for Defense Analyses, where he directed research and studies to support technical, programmatic, and policy issues in the defense, national security, and intelligence communities.

Good earned his Ph.D. at the Baylor College of Medicine and his B.S. at the University of North Carolina at Wilmington. His additional training includes the Sherman Kent School for Intelligence Analysis, the Army Institute for Professional Development, Government Affairs Institute Georgetown University, Defense Systems Management College, and Shipley Associates programs.

He is a Massachusetts Institute of Technology (MIT) Seminar XXI Fellow Class of 2004-05, and has served on numerous government committees and working groups, including Chair of the Infectious Disease Informatics Working Group (IDIWG); National Biodefense Assessment and Countermeasures Center (NBACC) Scientific Advisory Group; Department of Homeland Security, 2003-2006; and U.S. Special Operations Command (USSOCOM) Future Concepts Working Group (FCWG).

About SRI International
Innovations from SRI International have created new industries, billions of dollars of marketplace value, and lasting benefits to societytouching our lives every day. SRI, a nonprofit research and development institute based in Silicon Valley, brings its innovations to the marketplace through technology licensing, new products, and spin-off ventures. Government and business clients come to SRI for pioneering R&D and solutions in computing and communications, chemistry and materials, education, energy, health and pharmaceuticals, national defense, robotics, sensing, and more.

SOURCE SRI International



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES